People
The People
Governance grade: B+. A demerger-day board built to institutional spec — Heineken/Philips/Bain alumni, two-thirds-plus independent, KPMG audit, strong clawback and 500%-of-salary shareholding — but the CEO is a 35-year Unilever lifer, Unilever still owns 19.85%, and 22.6% of shareholders voted against the dilutive Foundation Plan at the first AGM.
1. The People Running This Company
CEO shares held
CFO shares held
CEO holding × base salary
The CEO already holds €5.95M of stock against a €1.25M base salary — 95% of which was acquired with personal cash after the December 2025 listing — and is one ratchet shy of the 500% shareholding requirement. The CFO has put in €2.06M but is only at 59% of his target. Both invested with cash, not at zero strike.
The leadership story is "Heineken-Philips-Bain meets Unilever Ice Cream." Van Boxmeer (Chair) and Hooft Graafland (ARC Chair) ran Heineken together for over a decade — they know how to operate a global drinks/snacking business out of the Netherlands. Bhattacharya (CFO) ran the 2016 Philips Lighting spin-off, the closest analog to what TMICC is now. The risk is at the top: Peter ter Kulve has spent his entire 35-year career at Unilever and was only formally promoted to lead Ice Cream in 2024 — investors are betting that a long-time Unilever executive can suddenly behave like an outsider operator now that the cord is cut. The Executive Leadership Team is also largely Unilever-lifer (Seçkin, Loh, Tanrıdağlı, Rozanski, Vilar, Desai, Gunning all from Unilever), with external hires concentrated at HR (Schellekens, ex-PepsiCo/Vodafone), Tech (O'Brien, ex-PepsiCo/Reckitt), Corporate Affairs (McKenzie-Gould, ex-M&S) and Creative (Barraux, ex-L'Oréal/P&G).
2. What They Get Paid
The 2025 bonus paid out at 95% of target on a 76% formulaic business outcome multiplied by a 125% strategic-priorities discretion add-back — the RemCo gave both Executive Directors the same individual multiplier, explicitly to reward "leading the successful separation and listing." That is defensible at IPO but the precedent is worth watching: a one-quarter financial miss was effectively offset by judgment. The legacy 2025 Performance Award (a 2024-era Unilever retention bonus) did not pay out because the stretch threshold was missed, which is a credibility tick. The 2024 Replacement PSP, however, is set to vest at 100% on-target in February 2027 with no real performance test because "the post-separation performance period was considered too short" — effectively a guaranteed payout for surviving the year.
CEO pay annualises to €4.58M (68× the €67.7K median employee), CFO to €1.98M (29×). RemCo benchmarks place TMICC CEO comp "around the lower quartile" of the AEX and CFO "around the median" — a reasonable starting position for a newly listed company. Variable pay is 70% of the CEO mix and 48% of the CFO mix.
Foundation Plan – the big-money plan still to come. Subject to the May-2026 AGM (passed with 77.4% for, 22.6% against), Executive Directors can co-invest up to 500% of base salary (CEO: €6.25M) and 400% (CFO: €3.5M) of personal cash into shares, in exchange for matching options at a 5:1 ratio. Options only vest if absolute share-price grows AND TSR outperforms peer median, with 5-year post-grant share-sale lockup. This is a real "skin-in-the-game" instrument, but the 22.6% against vote is the loudest investor dissent at the AGM.
3. Are They Aligned?
Skin-in-the-Game (1-10)
Unilever retained stake
All-director ownership
CEO shareholding × salary
Ownership and control
The CEO/CFO have put roughly €8M of personal money into the stock — that is real alignment by any standard, and was a precondition for the demerger story. But absolute insider ownership is tiny (0.15%) and management does not control the cap table. The dominant share story is the 19.85% Unilever overhang: it is not a promoter holding (Unilever publicly described it as a financial investment, voted proportionally at the first AGM, and intends to monetise over time), which means it is also a known supply overhang into 2026-27.
Insider activity since listing
There has been no insider selling since listing — every share held by Executive Directors and all non-Unilever NEDs was acquired with personal cash at IPO or in the open market afterwards. The disclosure regime is thinner than US Form 4 standards (NL/UK rules via AFM and 6-K), so investors should not equate "no disclosure" with "no activity"; but on a first-six-months read, no director has trimmed.
Dilution outlook
Cumulative theoretical dilution from existing and proposed equity plans sits at roughly 1.7% of the float, with the Foundation Plan accounting for the bulk. That is modest in absolute terms for a CPG large-cap, but it is concentrated in a 3-4 year window and only vests on TSR outperformance — so dilution and shareholder return are at least mechanically linked. The Board also took 10% issue/buyback authorities at the AGM with no stated intent to issue and 99.95% approval on the buyback authority, which is shareholder-friendly framing.
Related-party and capital-allocation behaviour
The main related-party exposure is the Transitional Services Agreement (TSA) with Unilever, which is an interim operating model running 2025-2027 covering shared services and a fixed-basis settlement of receivables/payables. Management has been explicit that TSAs phase out across 2026 and step down again in 2027 — investors should track this as a clean execution test. The single non-independent NED, Reginaldo Ecclissato, sits on the Nomination and Governance Committee while concurrently serving as a sitting Unilever Leadership Executive — that is a conflict by construction, not because of any specific action. He drew the highest "against" vote of any reappointment (1.83% against vs <1% for the rest).
Capital allocation is conservative for now: dividend policy targets a "progressive" path with an "investment-grade balance sheet" anchor, and FY2025 profit of €293M was fully retained. The 61.2M-share buyback authority (10% of capital) is on file but the Board "has no present intention" to issue beyond share-plan needs.
Skin-in-the-game scorecard
Skin-in-the-game score: 7 / 10. The framework is at the strong end of European market practice (high shareholding requirements, long lockups, statutory clawback, personal cash demanded). The deductions are: absolute insider ownership is still modest (CFO not yet at target), the 2024 Replacement PSP is a guaranteed-vest concession, and the 125% individual bonus multiplier got applied at the first opportunity. Score is bounded by it being a 6-month-old listing — much of the alignment is "future cash to be invested in 2026" rather than ten years of compounded ownership.
4. Board Quality
The board is built to institutional spec: independent Chair, separate SID/Vice-Chair, fully independent audit and remuneration committees, KPMG audit, 1-year director terms with a hard 9-year NED cap, statutory gender quota met. The depth of consumer expertise is genuine — van Boxmeer (Heineken CEO), Hooft Graafland (Heineken CFO), Bomhard (Imperial Brands CEO), Cartwright (Harvey Nichols / Burberry / Savills), Mondelēz exposure across the bench. Where the board is thinner is on direct ice-cream operating experience — that lives almost entirely in the ELT, not in the NEDs — and on independent-from-Unilever perspective: the founding non-executive cohort was substantially nominated in consultation with Unilever as sole pre-demerger shareholder. Reginaldo Ecclissato sitting on the Nomination & Governance Committee while still working for Unilever is the single weakest governance link — he is the right person to ensure transition continuity but the wrong person to vote on the next CEO or chair if Unilever's economic interests diverge from TMICC's.
The May 2026 AGM confirmed strong but not unanimous support: every director was reappointed with 95%+, every routine resolution cleared at 99%+, but the Foundation Plan drew 22.63% against — well above the 20% UK-code "red zone" that triggers a formal consultation. The Board has committed to continued engagement on the Foundation Plan rationale.
5. The Verdict
Governance grade
Skin-in-the-Game (1-10)
Rem. Policy vote — for (%)
Foundation Plan — for (%)
Strongest positives: Heineken/Philips/Bain-grade independent chair and committees; pay 70% variable with 500%-of-salary shareholding requirement and 5-7 year holding periods; CEO and CFO put €8M of personal cash into shares at IPO; 5-year statutory Dutch clawback; KPMG audit reappointed with 99.97% support.
Real concerns: Unilever still owns 19.85% and the CEO is a 35-year Unilever lifer, so true cultural independence is unproven; one NED (Ecclissato) sits on NomGov while still working for Unilever; the 2024 Replacement PSP vests at 100% on-target with no real performance test; the 125% individual bonus multiplier was applied at the first opportunity; 22.6% of shareholders voted against the Foundation Plan at the first AGM.
What would move the grade. Upgrade to A– if (i) Unilever monetises its 19.85% in an orderly manner during 2026, (ii) the Foundation Plan executes with CEO/CFO at or near max personal investment, and (iii) FY2026 bonus pays formulaically with no discretionary uplift. Downgrade to B–/C+ if Unilever's stake is used to block strategic flexibility, if Ecclissato remains on NomGov beyond the 2027 AGM, or if a second consecutive year sees discretion stretch a missed financial outcome into an on-target bonus.